Feedback

Mylan CEO Defends Price of EpiPen, Insists Company Isn't Price-Gouging

 

Heather Bresch, the CEO of Mylan Pharmaceuticals and the daughter of a prominent US senator, insisted that the rising price of the EpiPen is the result of the health care system in the U.S.

Shows